We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.29%
This Fund
S&P 500
This Quarter Est. Return
+9.27%
1 Year Est. Return
+106.29%
3 Year Est. Return
+266.67%
5 Year Est. Return
+310.43%
10 Year Est. Return
+1,579.99%
AUM
$1.65B
AUM Growth
+$191M
Cap. Flow
-$10.8B
Cap. Flow %
-654.14%
Top 10 Hldgs %
14.57%
Holding
1,395
New
459
Increased
207
Reduced
257
Closed
382
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISEE
976
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$71K ﹤0.01%
+12,507
New +$59.6K
BRPAR
977
DELISTED
Big Rock Partners Acquisition Corp. Right
BRPAR
$71K ﹤0.01%
287,077
FPRX
978
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$69K ﹤0.01%
14,586
-4,419
-23% -$22.4K
CALA
979
DELISTED
Calithera Biosciences, Inc
CALA
$68K ﹤0.01%
980
+100
+11% +$8.73K
GTEC icon
980
Greenland Technologies Holding
GTEC
$14.1M
$66K ﹤0.01%
+29,000
New +$83.5K
BIOX icon
981
Bioceres Crop Solutions
BIOX
$22.6M
$62K ﹤0.01%
+11,539
New +$65.3K
ATRS
982
DELISTED
Antares Pharma, Inc.
ATRS
$59K ﹤0.01%
21,746
+10,504
+93% +$29.1K
BLU
983
DELISTED
BELLUS Health Inc.
BLU
$54K ﹤0.01%
23,677
+11,494
+94% +$32.6K
LITS
984
Lite Strategy Inc
LITS
$31.5M
$53K ﹤0.01%
+852
New +$51.3K
AKBA icon
985
Akebia Therapeutics
AKBA
$255M
$52K ﹤0.01%
+20,620
New +$181K
DBVT
986
DBV Technologies
DBVT
$808M
$50K ﹤0.01%
2,910
ABUS icon
987
Arbutus Biopharma
ABUS
$895M
$41K ﹤0.01%
+13,218
New +$40.2K
COTY icon
988
Coty
COTY
$2.4B
$41K ﹤0.01%
+15,286
New +$57.7K
BXRX
989
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$38K ﹤0.01%
10
AUD
990
DELISTED
Audacy, Inc.
AUD
$35K ﹤0.01%
21,528
-2,910
-12% -$4.35K
TXMD icon
991
TherapeuticsMD
TXMD
$24.1M
$26K ﹤0.01%
325
-2,895
-90% -$231K
FENG
992
Phoenix New Media
FENG
$17.8M
$23K ﹤0.01%
3,135
-8,075
-72% -$73.7K
TPST icon
993
Tempest Therapeutics
TPST
$14.4M
$23K ﹤0.01%
71
-462
-87% -$157K
JFKKR
994
DELISTED
8i Enterprises Acquisition Corp Right
JFKKR
$19K ﹤0.01%
22,400
-277,600
-93% -$202K
CREXW
995
DELISTED
Creative Realities, Inc. Warrant
CREXW
$12K ﹤0.01%
12,236
TLGT
996
DELISTED
Teligent, Inc
TLGT
$10K ﹤0.01%
13,369
-1,027
-7% -$1.81K
AA icon
997
Alcoa
AA
$12.5B
-13,386
Closed -$150K
ACCO icon
998
Acco Brands
ACCO
$404M
-16,065
Closed -$114K
ADBE icon
999
PUT
Adobe
ADBE
$104B
-6
Closed -$261K
ADC icon
1000
Agree Realty
ADC
$9.5B
-10,400
Closed -$683K

Similar funds

Boothbay Fund Management's Q3 2020 Portfolio in Review

As of Q3 2020, Boothbay Fund Management held 1,395 positions worth $1.65B, up 13% from $1.46B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Boothbay Fund Management withdrew a net $10.8B in Q3 2020, closing 382 positions and reducing 257 holdings. Its most notable exit was Tesla, an estimated $10.7B position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Boothbay Fund Management opened a new position in Whiting Petroleum Corporation worth $6.63M.

  • Boothbay Fund Management's largest Q3 2020 buy was Whiting Petroleum Corporation: 383,266 shares worth $6.63M.
  • Boothbay Fund Management added most to Alphabet (Google) Class A in Q3 2020, an estimated $28.6M increase.
  • Boothbay Fund Management's biggest Q3 2020 reduction was KBR, cutting an estimated $45.7M.
  • Boothbay Fund Management fully exited Tesla in Q3 2020, selling an estimated $10.7B.
  • Boothbay Fund Management's ten largest holdings make up 15% of its $1.65B portfolio in Q3 2020.
  • Boothbay Fund Management opened 459 new positions and closed 382 in Q3 2020.
  • Boothbay Fund Management's portfolio value rose 13% quarter-over-quarter to $1.65B.

Based on Boothbay Fund Management's 13F filing for Q3 2020, filed 16 Nov 2020.